TWO SIGMA INVESTMENTS, LP - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 23 filers reported holding ADIAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,669
-40.8%
17,623
-0.5%
0.00%
Q1 2023$6,197
-50.6%
17,707
-69.7%
0.00%
Q4 2022$12,554
-37.2%
58,3890.0%0.00%
Q3 2022$20,000
-77.0%
58,389
+129.2%
0.00%
Q1 2019$87,000
+45.0%
25,472
+116.3%
0.00%
Q4 2018$60,00011,7750.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders